Author:
Molaei Hamideh, ,Davoudi-Monfared Esmat,Allahyari Fakhri,Hamedani Fereshte,Nejad Javad H., , , ,
Abstract
"Introduction: Human papillomavirus infection considers one of the leading causes of infection-related cancer worldwide. The general public's range of knowledge and understanding of human papillomavirus is low; the present study was done intending to evaluate the knowledge and attitude of patients with human papillomavirus and the effectiveness of educational intervention in those patients. Methods: This was a quasi-experimental study. The study population included patients with genital human papillomavirus referred to Dermatology Clinic of Baqiyatallah Hospital in 2020. The patients filled out a pre-test questionnaire. In the next step, they were trained by the treating physician about the disease, transmission ways, complications, treatment methods, and laboratory tests, and available vaccines. After that, an educational pamphlet was given to the patient to complete and review the information. Moreover, a post-test was performed in the patient's next visit. Data were analyzed using SPSS software version 22. Results: 92 patients were included in the study. The levels of knowledge and attitude of patients were between 50 to 65% before training and training had a significant impact on improving the level of knowledge and attitude of patients (P 0.001) so that the level of knowledge and attitude of patients reached above 95%. Demographic factors such as age, gender, marital status, and level of education were not related to the initial knowledge and attitude of individuals based on the statistical analysis (P 0.05). However, the knowledge of married people about the complications of the disease was more than single ones (P = 0.032). Conclusion: the level of knowledge about human papillomavirus and its complications, transmission ways, prevention and treatment is low, which has increased with training significantly "
Publisher
Asociatia Cadrelor Medicale din Spitalul Universitar de Urgenta Militar Central Dr. Carol Davila
Reference22 articles.
1. "1. Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2013 Dec 31;31:H1-31.
2. 2. Hartwig S, St Guily JL, Dominiak-Felden G, Alemany L, De Sanjosé S. Estimation of the overall burden of cancers, precancerous lesions, and genital warts attributable to 9-valent HPV vaccine types in women and men in Europe. Infect Agents Cancer. 2017 Dec;12(1):1-0.
3. 3. Castellsagué X, Alemany L, Quer M, Halec G, Quirós B, Tous S, et al, Alejo M. HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients. J Natl Cancer Inst. 2016 Jun 1;108(6):djv403.
4. 4. Weaver, B.A., Epidemiology and natural history of genital human papillomavirus infection. J Am Osteopath Assoc, 2006. 106(Supplement 1): p. S2.
5. Type-specific human papillomavirus prevalence in Iranian women with normal cervical cytology: the impact of current HPV vaccines;Hamkar;Intervirology,2017